30.06.2012
- Simon Lowth may only be the interim chief executive of AstraZeneca but he is ready to sign off on bold deals. The decision to pair up with Bristol-Myers Squibb to buy diabetes...
29.06.2012
- GlaxoSmithKline has once again extended its $2.6 billion offer to buy long-time partner Human Genome Sciences until July 20 as a hostile stand-off with the U.S. biotech company...
28.06.2012
- U.S. health regulators approved the first new weight-loss drug in 13 years, allowing Arena Pharmaceuticals to bring its Belviq pill to market as public health advocates push for...
25.06.2012
- U.S. regulators have ruled against Shire in a battle over generic copies of its hyperactivity drug Adderall XR, approving a cut-price version of the medicine from Actavis, which is...
24.06.2012
- Teva Pharmaceutical Industries rose more than 11% on Sunday after a U.S. court upheld Teva's patents for multiple sclerosis drug Copaxone well into 2015. Israel-based Teva, the...
20.06.2012
- Institutional investors doubt that treatments for Alzheimer's disease being developed by Pfizer and Eli Lilly will achieve the main goals of their ongoing late-stage trials, but...
19.06.2012
- Codexis on Monday announced it has been awarded the annual Presidential Green Chemistry Challenge Award from the U.S. Environmental Protection Agency (EPA) for the development of...
19.06.2012
- As part of a long-term strategic plan to further AMRI's discovery capabilities in India, AMRI, a global contract research and manufacturing organization, announced the hiring of...
